Latest news
Buzzing Stocks: Emcure Pharma gains 3% on USFDA EIR; PFC slips 3% after mixed Q1 earnings - Moneycontrol.comMoneycontrol.com · Mon, 10 Aug 2026 03:59:36 GMTEmcure Pharma shares hits 52-week high post USFDA EIR for Gujarat facility - TradingViewTradingView · Mon, 10 Aug 2026 01:52:00 GMTEmcure Pharma Receives USFDA Establishment Inspection Report for Sanand Facility - Medical DialoguesMedical Dialogues · Sun, 09 Aug 2026 16:14:21 GMTEmcure Pharma receives USFDA EIR for Sanand facility; regulator classifies it as 'VAI'; here's what it means - CNBC TV18CNBC TV18 · Sat, 08 Aug 2026 08:11:51 GMTCPC Scientific Announces U.S. FDA Pre-License Inspection (PLI) Successfully Completed at Its Hangzhou cGMP Manufacturing Facility for Hepcludex® API, Establishing a Proven Track Record Under the Stringent BLA Pathway - Business WireBusiness Wire · Wed, 05 Aug 2026 12:11:00 GMTCipla Gets USFDA Inspection Closure for InvaGen Plant - HDFC SkyHDFC Sky · Tue, 04 Aug 2026 04:45:00 GMTZydus Lifesciences Shares in Focus After USFDA Inspection Report - EquitypanditEquitypandit · Mon, 03 Aug 2026 08:04:00 GMTZydus receives USFDA EIR for Ahmedabad injectable facility with VAI status - Indian Pharma PostIndian Pharma Post · Mon, 03 Aug 2026 02:21:10 GMT